Anzeige
Mehr »
Login
Freitag, 04.10.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Citibank sagt $3.000 Gold voraus: Lernen Sie das Unternehmen kennen, das sich seit Jahren darauf vorbereitet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
1.086 Leser
Artikel bewerten:
(2)

China Oversea Land & Investment Won the "Most Honored Company" in the Asia Pacific Property Industry by the Institutional Investor Ranked TOP 3 in Six Categories

DJ China Oversea Land & Investment Won the "Most Honored Company" in the Asia Pacific Property Industry by the Institutional Investor Ranked TOP 3 in Six Categories

EQS Newswire / 23/06/2023 / 09:00 UTC+8 
 
China Oversea Land & Investment Won the "Most Honored Company" in the Asia Pacific Property Industry by the 
Institutional Investor 
Ranked TOP 3 in Six Categories 
 
 (Hong Kong, June 21, 2023) China Overseas Land & Investment Limited ("COLI" or "the Company"; Stock Code: 0688.HK) is 
pleased to announce that COLI was granted the "Most Honored Company" in Asia Pacific property industry in 2023 Asia 
Executive Team survey by the prestigious financial magazine Institutional Investor. Besides, the Company was ranked TOP 
3 in all six categories, including "Best CEO" , "Best CFO" , "Best Investor Relations Professional" , "Best Investor 
Relations Company" , "Best Investor Relations Program" , "Best Environmental, Social, and Governance (ESG) " and the 
newly added "Best Board of Directors". 
 
Institutional Investor attracted a record-breaking participants of 6,474 investors, portfolio managers and analysts 
from the world with an estimated USD2 trillion in Asia equities from the buy-side companies. The competition was quite 
fierce this year with 1,608 companies and 2,504 individuals nominated. The survey covered various core dimensions, 
including the financial disclosure, performance in investor services and communication, ESG practices and individual 
performance of CEO, CFO and Investor Relations Professionals, and the governance of the board of directors. The survey 
of Institutional Investor enjoys high recognition and authoritativeness and is reckoned as a golden investment standard 
for its objective and rigorous criteria and numerous global participants. 
 
COLI received multiple corporate and individual accolades. In terms of corporate awards, COLI secured TOP 3 rankings in 
"Best Investor Relations Program", "Best Investor Relations Company", "Best Board of Directors" and "Best ESG" in the 
Asia Pacific property industry. In terms of individual awards, our Executive Director and CEO Mr. Zhichao Zhang was 
honored as the "Best CEO" and our CFO Mr. Eddie Lui received the "Best CFO". Furthermore, due to our outstanding 
performance across all six categories, COLI was bestowed the prestigious title of "Most Honored Company", which 
reflected the capital market's recognition of COLI's excellent executive leadership and investor engagement over the 
past year. 
 
Looking ahead, COLI will continue to refine its investor relations management system, enhance its information 
disclosure transparency and strengthen its high-quality communication with the capital market. The Company will also 
focus on improving its corporate governance and fulfill its responsibilities in the environmental and social aspects to 
create long-term value for its shareholders, investors and other stakeholders. 
 
COLI was granted the "Most Honored Company" in the Asia Pacific property industry and Ranked TOP 3 in Six Categories, 
including "Best CEO" , "Best CFO" , "Best Investor Relations Professional" , "Best Investor Relations Company" , "Best 
Investor Relations Program" , "Best ESG" and the newly added "Best Board of Directors" 
 
-End- 
 
 
Asia Executive Team Survey of Institutional Investor 
Institutional Investor survey was highly regarded as the golden standard in the international investment community with 
a history of over 50 years. Its business spans North America, Latin America, Brazil, Europe, the Middle East, Africa, 
Asia, Japan, China, and other regions. It conducts executive team evaluations for companies in the Asia-Pacific region 
by carrying out a five-week voting period. All voters are equity analysts and fund managers with real-name 
authentication. 
 
 
File: China Oversea Land & Investment Won the "Most Honored Company" in the Asia Pacific Property Industry by the 
Institutional Investor Ranked TOP 3 in Six Categories 
23/06/2023 Dissemination of a Financial Press Release, transmitted by EQS News. 
The issuer is solely responsible for the content of this announcement. 
Media archive at www.todayir.com
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=cc93e7c38d86d9b681753c4512ab0534

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1663801&application_name=news

(END) Dow Jones Newswires

June 22, 2023 21:00 ET (01:00 GMT)

© 2023 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.